
TechBio is shifting from promise to reality. Our 2025 report reveals rising clinical-stage assets, major pharma partnerships, growing chemical synthesis automation, and a maturing funding landscape. Explore the data driving TechBio’s transformation of drug discovery and development.

Europe’s fragmented regulatory landscape slows founders and limits growth. We outline how unified rules, streamlined licensing, digital compliance, modern procurement, and faster company formation can unlock innovation across the EU.

Dronamics spent a decade building Europe’s first licensed cargo drone airline. From Bulgaria to a €30 million EU investment, discover how the Black Swan platform is reshaping logistics, unlocking underused airfields, and defining the next era of deep-tech innovation.
Discover more articles like this on the Speedinvest Blog